Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 135 articles:
HTML format



Single Articles


    November 2021
  1. FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
    COVID-19 Vaccination Rates in a Global HIV Cohort.
    J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
    PubMed     Abstract available


  2. BALAKRISHNA S, Wolfensberger A, Kachalov V, Roth JA, et al
    Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study.
    J Infect Dis. 2021 Nov 18. pii: 6430793. doi: 10.1093.
    PubMed     Abstract available


  3. DUARTE G, Muresan P, Ward S, Laimon L, et al
    Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV.
    J Infect Dis. 2021 Nov 16. pii: 6429421. doi: 10.1093.
    PubMed     Abstract available


  4. STOCKDALE AJ, Meiring JE, Shawa IT, Thindwa D, et al
    Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi.
    J Infect Dis. 2021 Nov 9. pii: 6424415. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  5. STERN J, Solomon A, Dantanarayana A, Pascoe R, et al
    Cell-associated HIV RNA has a Circadian Cycle in Males Living with HIV on Antiretroviral Therapy.
    J Infect Dis. 2021 Oct 16. pii: 6398479. doi: 10.1093.
    PubMed     Abstract available


  6. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    PubMed     Abstract available


  7. TINGGAARD M, Slotved HC, Fuursted K, Storgaard M, et al
    Oral and anal carriage of Streptococcus pneumoniae among sexually active men with HIV who have sex with men.
    J Infect Dis. 2021 Oct 8. pii: 6383604. doi: 10.1093.
    PubMed     Abstract available


  8. AKATA K, Leung JM, Yamasaki K, Filho FSL, et al
    Altered polarization and impaired phagocytic activity of lung macrophages in people with HIV and COPD.
    J Infect Dis. 2021 Oct 5. pii: 6381638. doi: 10.1093.
    PubMed     Abstract available


  9. LECUYER R, Issa N, Tessoulin B, Lavergne RA, et al
    Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia.
    J Infect Dis. 2021 Oct 4. pii: 6380657. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  10. PELUSO MJ, Lu S, Tang AF, Durstenfeld MS, et al
    Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021 Sep 27. pii: 6376537. doi: 10.1093.
    PubMed     Abstract available


  11. GAY CL, James KS, Tuyishime M, Falcinelli SD, et al
    Stable Latent HIV Infection and Low-Level Viremia Despite Treatment with the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
    J Infect Dis. 2021 Sep 25. pii: 6375363. doi: 10.1093.
    PubMed     Abstract available


  12. WARD KM, Falade-Nwulia O, Moon J, Sutcliffe CG, et al
    Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs.
    J Infect Dis. 2021 Sep 20. pii: 6372878. doi: 10.1093.
    PubMed     Abstract available


  13. WALKER J, Soeters HM, Novak R, Diallo AO, et al
    Modeling Optimal Laboratory Testing Strategies for Bacterial Meningitis Surveillance in Africa.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


    August 2021
  14. PETERS BA, Moon JY, Hanna DB, Kutsch O, et al
    T-cell immune dysregulation and mortality in women with HIV.
    J Infect Dis. 2021 Aug 27. pii: 6358605. doi: 10.1093.
    PubMed     Abstract available


  15. VAN DER HEIJDEN WA, van Deuren RC, van de Wijer L, van den Munckhof ICL, et al
    Clonal hematopoiesis is associated with low CD4 nadir and increased residual HIV transcriptional activity in virally suppressed individuals with HIV.
    J Infect Dis. 2021 Aug 21. pii: 6356061. doi: 10.1093.
    PubMed     Abstract available


  16. GOODEN TE, Gardner M, Wang J, Jolly K, et al
    Incidence of cardiometabolic diseases in people living with and without HIV in the UK: a population-based matched cohort study.
    J Infect Dis. 2021 Aug 21. pii: 6356062. doi: 10.1093.
    PubMed     Abstract available


  17. PALICH R, Teyssou E, Sayon S, Abdi B, et al
    Kinetics of archived M184V mutation in treatment-experienced virally suppressed HIV-infected patients.
    J Infect Dis. 2021 Aug 20. pii: 6355381. doi: 10.1093.
    PubMed     Abstract available


  18. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years.
    J Infect Dis. 2021;224:657-666.
    PubMed     Abstract available


  19. SORTINO O, Dias J, Anderson M, Laidlaw E, et al
    Preserved Mucosal-Associated Invariant T-Cell Numbers and Function in Idiopathic CD4 Lymphocytopenia.
    J Infect Dis. 2021;224:715-725.
    PubMed     Abstract available


  20. HEARPS AC, Angelovich TA, Trevillyan JM, Wong ME, et al
    Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk.
    J Infect Dis. 2021;224:667-672.
    PubMed     Abstract available


  21. MCMAHON DK, Zheng L, Cyktor JC, Aga E, et al
    A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2021;224:648-656.
    PubMed     Abstract available


  22. KREISEL KM, Llata E, Haderxhanaj L, Pearson WS, et al
    The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006-2016.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  23. DAVIS GS, Horner PJ, Price MJ, Mitchell HD, et al
    What Do Diagnoses of Pelvic Inflammatory Disease in Specialist Sexual Health Services in England Tell Us About Chlamydia Control?
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  24. PIETROBON AJ, Yoshikawa FSY, Oliveira LM, Pereira NZ, et al
    Antiviral Response Induced by TLR7/TLR8 Activation Inhibits HIV-1 Infection in Cord Blood Macrophages.
    J Infect Dis. 2021 Aug 6. pii: 6342784. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  25. GIL RM, Freeman T, Mathew T, Kullar R, et al
    The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers.
    J Infect Dis. 2021 Jul 29. pii: 6330600. doi: 10.1093.
    PubMed     Abstract available


  26. DA SILVA J, Pals S, Chang J, Hackett S, et al
    Monitoring emerging HIV drug resistance in sub-Saharan Africa in the era of dolutegravir.
    J Infect Dis. 2021 Jul 20. pii: 6324299. doi: 10.1093.
    PubMed     Abstract available


  27. DURAN RAMIREZ JJ, Ballouz T, Nguyen H, Kusejko K, et al
    Increasing Frequency and Transmission of HIV-1 Non-B Subtypes among Men Who Have Sex with Men in the Swiss HIV Cohort Study.
    J Infect Dis. 2021 Jul 14. pii: 6321357. doi: 10.1093.
    PubMed     Abstract available


  28. RONIT A, Omland LH, Kronborg G, Pedersen G, et al
    Incidence of chronic obstructive pulmonary disease in people with HIV, their parents and siblings in Denmark.
    J Infect Dis. 2021 Jul 14. pii: 6321339. doi: 10.1093.
    PubMed     Abstract available


  29. SPRADLING PR, Xing J, Harris AM, Ly KN, et al
    Estimated prevalence and number of persons with isolated antibody to hepatitis B core antigen and associated occult hepatitis B, United States, 2001-2018.
    J Infect Dis. 2021 Jul 12. pii: 6319558. doi: 10.1093.
    PubMed     Abstract available


  30. GUMBO A, Topazian HM, Mwanza A, Mitchell CL, et al
    Occurrence and Distribution of Non-falciparum Malaria Parasite Species among Adolescents and Adults in Malawi.
    J Infect Dis. 2021 Jul 9. pii: 6318237. doi: 10.1093.
    PubMed     Abstract available


  31. BOWMAN NM, Balasubramanian S, Gilman RH, Parobek C, et al
    Deep sequencing to detect diversity of Trypanosoma cruzi infection in patients co-infected with HIV and Chagas disease.
    J Infect Dis. 2021 Jul 8. pii: 6317582. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  32. PETERS BA, Xue X, Sheira LA, Qi Q, et al
    Menopause is associated with immune activation in women with HIV.
    J Infect Dis. 2021 Jun 26. pii: 6310126. doi: 10.1093.
    PubMed     Abstract available


  33. ESTEBAN-CANTOS A, Montejano R, Rodriguez-Centeno J, Saiz-Medrano G, et al
    Longitudinal changes in epigenetic age acceleration in aviremic HIV-infected recipients of long-term antiretroviral treatment.
    J Infect Dis. 2021 Jun 24. pii: 6309028. doi: 10.1093.
    PubMed     Abstract available


  34. GHOSN J, Assoumou L, Lascoux-Combe C, Peytavin G, et al
    HIV-1-RNA kinetics in blood plasma and in seminal plasma of men starting a dolutegravir-based triple-combination regimen at the time of primary HIV-1 infection.
    J Infect Dis. 2021 Jun 24. pii: 6309026. doi: 10.1093.
    PubMed     Abstract available


  35. BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
    Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
    J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
    PubMed     Abstract available


  36. ROSENBERG ES, Tesoriero JM
    A Tale of Many New York Cities.
    J Infect Dis. 2021 Jun 4. pii: 6291934. doi: 10.1093.
    PubMed    


  37. RAGONNET-CRONIN M, Golubchik T, Moyo S, Fraser C, et al
    HIV genetic diversity informs stage of HIV-1 infection among patients receiving antiretroviral therapy in Botswana.
    J Infect Dis. 2021 Jun 2. pii: 6291357. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  38. KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
    Corrigendum to: Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results.
    J Infect Dis. 2021 May 31. pii: 6289906. doi: 10.1093.
    PubMed    


  39. HORSBURGH BA, Hiener B, Fisher K, Lee E, et al
    Cellular activation, differentiation and proliferation influence the dynamics of genetically-intact proviruses over time.
    J Infect Dis. 2021 May 26. pii: 6284332. doi: 10.1093.
    PubMed     Abstract available


  40. RAVINDRAN J, Richardson B, Kinuthia J, Unger JA, et al
    Chlamydia, gonorrhea, and incident HIV infection during pregnancy predict preterm birth despite treatment.
    J Infect Dis. 2021 May 23. pii: 6282455. doi: 10.1093.
    PubMed     Abstract available


  41. TAMARGO JA, Hernandez-Boyer J, Teeman C, Martin HR, et al
    Immune activation: A link between food insecurity and chronic disease in people living with HIV.
    J Infect Dis. 2021 May 16. pii: 6276422. doi: 10.1093.
    PubMed     Abstract available


  42. CHA S, Henry A, Montgomery MP, Laws RL, et al
    Morbidity and Mortality among Adults Experiencing Homelessness Hospitalized with COVID-19.
    J Infect Dis. 2021 May 16. pii: 6276529. doi: 10.1093.
    PubMed     Abstract available


  43. BRUCE-BRAND C, Schubert PT, Wright CA
    HIV, placental pathology and birth outcomes - a brief overview.
    J Infect Dis. 2021 May 14. pii: 6275456. doi: 10.1093.
    PubMed     Abstract available


  44. GABRIELAITE M, Bennedbaek M, Zucco AG, Ekenberg C, et al
    Human immunotypes impose selection on viral genotypes through viral epitope specificity.
    J Infect Dis. 2021 May 11. pii: 6273783. doi: 10.1093.
    PubMed     Abstract available


  45. GUERRERO-MARTIN SM, Rubin LH, McGee KM, Shirk EN, et al
    Psychosocial Stress Alters the Immune Response and Results in Higher Viral Load During Acute SIV Infection in a Pigtailed Macaque Model of HIV.
    J Infect Dis. 2021 May 10. pii: 6273219. doi: 10.1093.
    PubMed     Abstract available


  46. MILLAR JR, Bengu N, Vieira VA, Adland E, et al
    Early initiation of antiretroviral therapy following in utero HIV infection is associated with low viral reservoirs but other factors determine subsequent plasma viral rebound.
    J Infect Dis. 2021 May 8. pii: 6272368. doi: 10.1093.
    PubMed     Abstract available


  47. MCFARLAND EJ, Cunningham CK, Muresan P, Capparelli EV, et al
    Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
    J Infect Dis. 2021 May 2. pii: 6261970. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  48. LY KN, Xing J, Spradling PR
    Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018.
    J Infect Dis. 2021 Apr 27. pii: 6254685. doi: 10.1093.
    PubMed     Abstract available


  49. BEBELL LM, Parks K, Le MH, Ngonzi J, et al
    Placental decidual arteriopathy and vascular endothelial growth factor A (VEGF-A) expression among women with and without HIV.
    J Infect Dis. 2021 Apr 21. pii: 6242421. doi: 10.1093.
    PubMed     Abstract available


  50. IKUMI NM, Pillay K, Tilburgs T, Malaba TR, et al
    T cell Homeostatic Imbalance in Placentae from Women with HIV in the absence of Vertical Transmission.
    J Infect Dis. 2021 Apr 21. pii: 6242402. doi: 10.1093.
    PubMed     Abstract available


  51. KALA S, Meteleva K, Serghides L
    ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection.
    J Infect Dis. 2021 Apr 21. pii: 6242371. doi: 10.1093.
    PubMed     Abstract available


  52. BARES SH, Smeaton LM, Scott SE, Smith BA, et al
    The Association Between Weight Gain, Sex and Immune Activation Following the Initiation of Antiretroviral Therapy.
    J Infect Dis. 2021 Apr 19. pii: 6236102. doi: 10.1093.
    PubMed     Abstract available


  53. TAILOR J, Foldi J, Generoso M, McCarty B, et al
    Disease Progression in Children with Perinatal HIV Correlates with Increased PD-1+ CD8 T Cells that Coexpress Multiple Immune Checkpoints.
    J Infect Dis. 2021 Apr 17. pii: 6231805. doi: 10.1093.
    PubMed     Abstract available


  54. KATSUYA H, Cook LBM, Rowan AG, Melamed A, et al
    Clonality of HIV-1 and HTLV-1 infected cells in naturally coinfected individuals.
    J Infect Dis. 2021 Apr 12. pii: 6222242. doi: 10.1093.
    PubMed     Abstract available


  55. EISINGER RW, Lerner AM, Fauci AS
    HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics.
    J Infect Dis. 2021 Apr 7. pii: 6167835. doi: 10.1093.
    PubMed     Abstract available


  56. RAFFENBERG M, Engel T, Schoepf IC, Kootstra NA, et al
    Impact of Delaying Antiretroviral Treatment during Primary HIV Infection on Telomere Length.
    J Infect Dis. 2021 Apr 5. pii: 6211111. doi: 10.1093.
    PubMed     Abstract available


  57. KENYON C
    Dual azithromycin/ceftriaxone therapy for gonorrhoea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold.
    J Infect Dis. 2021 Apr 2. pii: 6209316. doi: 10.1093.
    PubMed    


  58. JANSEN K, Selb R, Banhart S, Buder S, et al
    Reponse to Kenyon.
    J Infect Dis. 2021 Apr 2. pii: 6209317. doi: 10.1093.
    PubMed    


    March 2021
  59. LOHMAN-PAYNE B, Koster J, Gabriel B, Chilengi R, et al
    Persistent Immune activation in HIV-Infected Pregnant Women Initiating cART Post Conception.
    J Infect Dis. 2021 Mar 29. pii: 6199840. doi: 10.1093.
    PubMed     Abstract available


  60. BLAZKOVA J, Huiting ED, Boddapati AK, Shi V, et al
    TIGIT expression on CD8+ T cells correlates with higher cytotoxic capacity.
    J Infect Dis. 2021 Mar 21. pii: 6179305. doi: 10.1093.
    PubMed     Abstract available


  61. MARZINKE MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, et al
    Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083.
    J Infect Dis. 2021 Mar 19. pii: 6178946. doi: 10.1093.
    PubMed     Abstract available


  62. GOUPIL DE BOUILLE J, Vigouroux C, Plessis L, Ghislain M, et al
    Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers.
    J Infect Dis. 2021 Mar 19. pii: 6178947. doi: 10.1093.
    PubMed     Abstract available


  63. WU G, Zuck P, Goh SL, Milush JM, et al
    Gag p24 is a Marker of HIV Expression in Tissues and Correlates with Immune Response.
    J Infect Dis. 2021 Mar 9. pii: 6164924. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  64. RYOM L, Lundgren JD, Reiss P, Ross M, et al
    The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.
    J Infect Dis. 2021;223:632-637.
    PubMed     Abstract available


  65. AJAYKUMAR A, Zhu M, Kakkar F, Brophy J, et al
    Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    J Infect Dis. 2021;223:621-631.
    PubMed     Abstract available


  66. POPOVICH KJ
    Using Genomic Sequencing to Delineate Community Networks of Methicillin-Resistant Staphylococcus aureus Transmission Among Men Who Have Sex With Men.
    J Infect Dis. 2021;223:543-546.
    PubMed    


  67. VUJKOVIC-CVIJIN I, Sortino O, Verheij E, Wit FW, et al
    The complement pathway is activated in people with HIV and is associated with non-AIDS comorbidities.
    J Infect Dis. 2021 Feb 19. pii: 6144980. doi: 10.1093.
    PubMed     Abstract available


  68. CHUAYPEN N, Jinato T, Avihingsanon A, Chirapongsathorn S, et al
    Improvement of Gut Diversity and Composition after Direct-Acting Antivirals in HCV-Infected Patients with or without HIV Coinfection.
    J Infect Dis. 2021 Feb 17. pii: 6141513. doi: 10.1093.
    PubMed     Abstract available


  69. BANHART S, Selb R, Oehlmann S, Bender J, et al
    The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018.
    J Infect Dis. 2021 Feb 16. pii: 6138844. doi: 10.1093.
    PubMed     Abstract available


  70. LI C, Mori L, Valente ST
    The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  71. SILICIANO JD, Siliciano RF
    Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  72. LI JZ, Gandhi RT
    The Search for an HIV Cure: Where Do We Go From Here?
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  73. LI Y, Mohammadi A, Li JZ
    Challenges and Promise of Human Immunodeficiency Virus Remission.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  74. ROSSIGNOL E, Alter G, Julg B
    Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  75. KASEKE C, Tano-Menka R, Senjobe F, Gaiha GD, et al
    The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  76. ZHOU Y, Maldini CR, Jadlowsky J, Riley JL, et al
    Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  77. FRANCESCHINI E, De Biasi S, Digaetano M, Bianchini E, et al
    Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy.
    J Infect Dis. 2021;223:482-493.
    PubMed     Abstract available


  78. MAHOMED S, Garrett N, Baxter C, Abdool Karim Q, et al
    Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
    J Infect Dis. 2021;223:370-380.
    PubMed     Abstract available


  79. CYKTOR JC, Bosch RJ, Mar H, Macatangay BJ, et al
    Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
    J Infect Dis. 2021;223:462-470.
    PubMed     Abstract available


  80. SERRANO-VILLAR S, Sanchez-Carrillo S, Talavera-Rodriguez A, Lelouvier B, et al
    Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery.
    J Infect Dis. 2021;223:471-481.
    PubMed     Abstract available


  81. CHITNENI P, Matthews LT
    The Other U=U. Untested and Untreated genital tract inflammation in people living with and exposed to HIV.
    J Infect Dis. 2021 Feb 10. pii: 6131968. doi: 10.1093.
    PubMed    


  82. WALL KM, Karita E, Nyombayire J, Ingabire R, et al
    Genital abnormalities, hormonal contraception, and HIV transmission risk in Rwandan serodifferent couples.
    J Infect Dis. 2021 Feb 9. pii: 6131738. doi: 10.1093.
    PubMed     Abstract available


  83. RON R, Cabello A, Gosalbes MJ, Sanchez-Conde M, et al
    Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex With Men.
    J Infect Dis. 2021 Feb 5. pii: 6129308. doi: 10.1093.
    PubMed     Abstract available


  84. MARGOLIS DM
    Measuring the Haystack's Needles.
    J Infect Dis. 2021;223:184-186.
    PubMed    


    January 2021
  85. PARK SY, Faraci G, Murphy G, Pilcher C, et al
    Microdrop HIV sequencing for incidence and drug resistance surveillance.
    J Infect Dis. 2021 Jan 31. pii: 6124747. doi: 10.1093.
    PubMed     Abstract available


  86. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    PubMed     Abstract available


  87. EATON EF, Clement ME
    Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
    J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
    PubMed    


  88. MASTRO TD, Bateganya M, Mahler H
    The need to optimize HIV test and treat in Africa.
    J Infect Dis. 2021 Jan 21. pii: 6104550. doi: 10.1093.
    PubMed    


  89. GRABOWSKI MK, Patel EU, Nakigozi G, Ssempijja V, et al
    Prevalence and predictors of persistent HIV viremia and viral rebound following universal test and treat: a population-based study.
    J Infect Dis. 2021 Jan 20. pii: 6104546. doi: 10.1093.
    PubMed     Abstract available


  90. ROUTY JP, Isnard S
    Beyond the absence of CD4 T-cell count: A novel genetic CD4 T-cell deficiency disorder with a contingency plan.
    J Infect Dis. 2021 Jan 18. pii: 6103163. doi: 10.1093.
    PubMed    


  91. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
    Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
    J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
    PubMed     Abstract available


  92. PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
    Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
    J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
    PubMed     Abstract available


  93. MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
    Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
    J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
    PubMed     Abstract available


  94. GAISA MM, Sigel KM, Deshmukh AA, Lenskaya V, et al
    Comparing Anal Cancer Screening Algorithms Using Cytology and HPV DNA Testing in Three High-risk Populations.
    J Infect Dis. 2021 Jan 3. pii: 6060069. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  95. JANKOWSKI CM, Wilson MP, MaWhinney S, Reusch J, et al
    Blunted muscle mitochondrial responses to exercise training in older adults with HIV.
    J Infect Dis. 2020 Dec 30. pii: 6055584. doi: 10.1093.
    PubMed     Abstract available


  96. KROEZE S, Rossouw TM, Steel HC, Wit FW, et al
    Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy.
    J Infect Dis. 2020 Dec 29. pii: 6054994. doi: 10.1093.
    PubMed     Abstract available


  97. RAWAT P, Brummel SS, Singh KK, Kim J, et al
    Genomics Links Inflammation with Neurocognitive Impairment in Children Living with Human Immunodeficiency Virus type-1.
    J Infect Dis. 2020 Dec 29. pii: 6054995. doi: 10.1093.
    PubMed     Abstract available


  98. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.
    J Infect Dis. 2020 Dec 26. pii: 6053002. doi: 10.1093.
    PubMed     Abstract available


  99. SORTINO O, Dias J, Anderson M, Laidlaw E, et al
    Preserved MAIT cell numbers and function in idiopathic CD4 lymphocytopenia.
    J Infect Dis. 2020 Dec 25. pii: 6047591. doi: 10.1093.
    PubMed     Abstract available


  100. HEARPS AC, Angelovich TA, Trevillyan JM, Wong ME, et al
    Rosuvastatin therapy in people with HIV at intermediate cardiovascular risk does not decrease biomarkers of inflammation and immune activation.
    J Infect Dis. 2020 Dec 22. pii: 6044066. doi: 10.1093.
    PubMed     Abstract available


  101. MCMAHON DK, Zheng L, Cyktor JC, Aga E, et al
    A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
    J Infect Dis. 2020 Dec 22. pii: 6043307. doi: 10.1093.
    PubMed     Abstract available


  102. MANION M, Dulanto Chiang A, Pei L, Wong CS, et al
    Disseminated Mycobacterium marinum in HIV unmasked by Immune Reconstitution Inflammatory Syndrome.
    J Infect Dis. 2020 Dec 18. pii: 6041190. doi: 10.1093.
    PubMed     Abstract available


  103. KIRKEGAARD-KLITBO DM, Bendtsen F, Lundgren J, de Knegt RJ, et al
    Increased prevalence of liver fibrosis in people living with HIV without viral hepatitis compared to population controls.
    J Infect Dis. 2020 Dec 15. pii: 6035145. doi: 10.1093.
    PubMed     Abstract available


  104. JIANG W, Luo Z, Stephenson S, Li H, et al
    Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury.
    J Infect Dis. 2020 Dec 15. pii: 6035152. doi: 10.1093.
    PubMed     Abstract available


  105. SUNDERMANN EE, Bondi MW, Campbell LM, Gouaux B, et al
    Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders.
    J Infect Dis. 2020 Dec 15. pii: 6034152. doi: 10.1093.
    PubMed     Abstract available


  106. MARTIN AR, Bender AM, Hackman J, Kwon KJ, et al
    Similar frequency and inducibility of intact HIV-1 proviruses in blood and lymph nodes.
    J Infect Dis. 2020 Dec 3. pii: 6017470. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  107. JEYARAJAN AJ, Chung RT
    Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  108. ROCKSTROH JK, Boesecke C
    Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  109. POYNTEN IM, Jin F, Garland SM, Hillman RJ, et al
    HIV, immune dysfunction and the natural history of anal high-risk human papillomavirus infection in gay and bisexual men.
    J Infect Dis. 2020 Nov 21. pii: 5998258. doi: 10.1093.
    PubMed     Abstract available


  110. FALCINELLI SD, Kilpatrick KW, Read J, Murtagh R, et al
    Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of ART-treated individuals.
    J Infect Dis. 2020 Nov 20. pii: 5995716. doi: 10.1093.
    PubMed     Abstract available


  111. MEYER-MYKLESTAD MH, Medhus AW, Lorvik KB, Seljeflot I, et al
    HIV-infected immunological non-responders have colon-restricted gut mucosal immune dysfunction.
    J Infect Dis. 2020 Nov 20. pii: 5995605. doi: 10.1093.
    PubMed     Abstract available


  112. BERTAGNOLIO S, Hermans L, Jordan MR, Avila-Rios S, et al
    Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
    J Infect Dis. 2020 Nov 17. pii: 5986606. doi: 10.1093.
    PubMed     Abstract available


  113. LAPOINTE HR, Harrigan PR
    Human Immunodeficiency Virus Phylogenetics in the United States-and Elsewhere.
    J Infect Dis. 2020;222:1939-1940.
    PubMed    


  114. DEESE J, Wang M, Lapple D, Nelson JAE, et al
    What's sex got to do with it? Understanding potential confounding and exposure misclassification in mechanistic sexually transmitted infection research.
    J Infect Dis. 2020 Nov 12. pii: 5974974. doi: 10.1093.
    PubMed     Abstract available


  115. DIETRICH LG, Thorball CW, Ryom L, Burkhalter F, et al
    Rapid Progression of Kidney Dysfunction in Swiss People Living with HIV: Contribution of Polygenic Risk Score and D:A:D Clinical Risk Score.
    J Infect Dis. 2020 Nov 5. pii: 5957071. doi: 10.1093.
    PubMed     Abstract available


  116. HALEY DF, Edmonds A, Ramirez C, French AL, et al
    Direct-acting antiviral Hepatitis C treatment cascade and barriers to treatment initiation among US men and women with and without HIV.
    J Infect Dis. 2020 Nov 3. pii: 5952700. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  117. LUONG NGUYEN LB, Freedberg KA, Wanjala S, Maman D, et al
    Comparative effectiveness of interventions to improve the HIV continuum of care and HIV Pre-Exposure Prophylaxis in Kenya: a model-based analysis.
    J Infect Dis. 2020 Oct 27. pii: 5940739. doi: 10.1093.
    PubMed     Abstract available


  118. BREGLIO KF, Vinhaes CL, Arriaga MB, Nason M, et al
    Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with HIV.
    J Infect Dis. 2020 Oct 26. pii: 5940424. doi: 10.1093.
    PubMed     Abstract available


  119. DONOVAN J, Tram TTB, Phu NH, Hiep NTT, et al
    The influence of Strongyloides stercoralis co-infection on the presentation, pathogenesis and outcome of tuberculous meningitis.
    J Infect Dis. 2020 Oct 26. pii: 5940016. doi: 10.1093.
    PubMed     Abstract available


  120. MINAB R, Bu W, Nguyen H, Wall A, et al
    Maternal Epstein-Barr virus-specific antibodies and risk of infection in Ugandan infants.
    J Infect Dis. 2020 Oct 23. pii: 5936635. doi: 10.1093.
    PubMed     Abstract available


  121. DAVY-MENDEZ T, Napravnik S, Hogan BC, Althoff KN, et al
    Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015.
    J Infect Dis. 2020 Oct 21. pii: 5934541. doi: 10.1093.
    PubMed     Abstract available


  122. OLSON A, Coote C, Snyder-Cappione JE, Lin N, et al
    HIV-1 transcription but not intact provirus levels are associated with systemic inflammation.
    J Infect Dis. 2020 Oct 19. pii: 5930820. doi: 10.1093.
    PubMed     Abstract available


  123. YOSHIKAWA S, Yoshio S, Yoshida Y, Tsutsui Y, et al
    Impact of Immune Reconstitution-induced Hepatic Flare on HBsAg Loss in HBV/HIV-1-Coinfected Patients.
    J Infect Dis. 2020 Oct 19. pii: 5929874. doi: 10.1093.
    PubMed     Abstract available


  124. FICHTENBAUM CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, et al
    Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
    J Infect Dis. 2020 Oct 17. pii: 5928646. doi: 10.1093.
    PubMed    


  125. SLYKER JA, Guthrie B, Pankau M, Tapia K, et al
    Cytomegalovirus and Epstein-Barr virus viremia are associated with HIV DNA levels in the reservoir of Kenyan infants on antiretroviral therapy.
    J Infect Dis. 2020 Oct 16. pii: 5926738. doi: 10.1093.
    PubMed     Abstract available


  126. IKEUCHI K, Adachi E, Sasaki T, Suzuki M, et al
    An outbreak of USA300 MRSA among people with HIV in Japan.
    J Infect Dis. 2020 Oct 15. pii: 5923726. doi: 10.1093.
    PubMed     Abstract available


  127. TIRABOSCHI JM, Rojas J, Zetterberg H, Blennow K, et al
    No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62).
    J Infect Dis. 2020 Oct 13. pii: 5922599. doi: 10.1093.
    PubMed     Abstract available


  128. LUSCOMBE CA, Avihingsanon A, Supparatpinyo K, Gatechompol S, et al
    Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy modulates inflammation and immune cells functions.
    J Infect Dis. 2020 Oct 10. pii: 5920638. doi: 10.1093.
    PubMed     Abstract available


  129. KIRK GD, Astemborski J, Mehta SH, Ritter KD, et al
    Non-structured treatment interruptions are associated with higher HIV reservoir size measured by intact proviral DNA assay in people who inject drugs.
    J Infect Dis. 2020 Oct 10. pii: 5920557. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  130. THUDIUM RF, Knudsen AD, Stemann JHV, Hove-Skovsgaard M, et al
    Independent Association of Interleukin 6 With Low Dynamic Lung Function and Airflow Limitation in Well-Treated People With Human Immunodeficiency Virus.
    J Infect Dis. 2020 Sep 24. pii: 5910961. doi: 10.1093.
    PubMed     Abstract available


  131. YANG CX, Schon E, Obeidat M, Kobor MS, et al
    Accelerated Epigenetic Aging and Methylation Disruptions Occur in Human Immunodeficiency Virus Infection Prior to Antiretroviral Therapy.
    J Infect Dis. 2020 Sep 22. pii: 5909822. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  132. MCCREERY RJ, Florescu DF, Kalil AC
    Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  133. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Extent of in-utero transfer of tenofovir from mother to fetus: a paired analysis of hair specimens collected at birth from a cohort in the United States.
    J Infect Dis. 2020 Jul 4. pii: 5867166. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  134. BARROSO LF
    The Natural History of Anal Dysplasia: Unwrapping the Riddle to Find an Enigma.
    J Infect Dis. 2020;222:7-8.
    PubMed    


    October 2019
  135. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: